Biolojic Design, based in Tel Aviv and Boston, aims to transform antibodies into intelligent medicinal solutions through computational design. By creating a pipeline of single and multi-specific antibodies that precisely target predetermined epitopes to carry out unique biological programs, the technology company believes it can offer therapies for various diseases. Biolojic employs its unique AI platform to design antibodies with novel therapeutic properties, focusing on cancer and autoimmune illnesses . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post The Logical Song: Biolojic Design Reimagines Antibodies into “Smart” Therapeutics appeared first on GEN – Genetic Engineering and Biotechnology News.
